Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3,5-dibromotyrosine
2. 3,5-dibromotyrosine, (l)-isomer
1. 300-38-9
2. Dibromotyrosine
3. H-tyr(3,5-dibr)-oh
4. 3,5-dibromotyrosine
5. Dibry
6. 3,5 Dibromotyrosine
7. Biotiren
8. Bromotiren
9. L-tyrosine, 3,5-dibromo-
10. (s)-2-amino-3-(3,5-dibromo-4-hydroxyphenyl)propanoic Acid
11. (2s)-2-amino-3-(3,5-dibromo-4-hydroxyphenyl)propanoic Acid
12. Dibromotirina
13. Chebi:28335
14. Nsc 210786
15. Qd49lep46e
16. Tyrosine, 3,5-dibromo-, L-
17. Nsc-210786
18. Unii-qd49lep46e
19. H-tyr(3,5-br2)-oh
20. Bromotiren (tn)
21. Einecs 206-091-5
22. .beta.-(3,5-dibromo-4-hydroxyphenyl)alanine
23. Beta-(3,5-dibromo-4-hydroxyphenyl)alanine
24. 3,5-dibromo-1-tyrosine
25. Epitope Id:122958
26. Ncistruc1_001842
27. Ncistruc2_001476
28. Mls000069536
29. Schembl145219
30. Dibromotyrosine [mart.]
31. Chembl1232132
32. Dibromotyrosine [who-dd]
33. Zinc57299
34. Dtxsid401015579
35. Hms2234d11
36. H-tyr(3,5-br2)-oh.nh2o
37. Ccg-36649
38. Mfcd00037204
39. Ncgc00014584
40. Nci210786
41. 3,5-dibromo-4-hydroxyphenylalanine #
42. Akos015907823
43. 3,5-dibromo-l-tyrosine [mi]
44. Am83553
45. Db07637
46. Hy-w105101
47. Ncgc00014584-02
48. Ncgc00097688-01
49. As-57041
50. Smr000058595
51. Db-022010
52. Cs-0157743
53. D0213
54. Vu0285634-2
55. 3,5-dibromo-l-tyrosine Monohydrate (salt/mix)
56. C03224
57. D-1700
58. D08659
59. D89615
60. 300t389
61. A820156
62. Q3706879
63. Dby
| Molecular Weight | 338.98 g/mol |
|---|---|
| Molecular Formula | C9H9Br2NO3 |
| XLogP3 | -0.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 338.89287 g/mol |
| Monoisotopic Mass | 336.89492 g/mol |
| Topological Polar Surface Area | 83.6 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 227 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
H - Systemic hormonal preparations, excl. sex hormones and insulins
H03 - Thyroid therapy
H03B - Antithyroid preparations
H03BX - Other antithyroid preparations
H03BX02 - Dibromotyrosine
Global Sales Information
ABOUT THIS PAGE
A 3,5-Dibromo-L-Tyrosine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3,5-Dibromo-L-Tyrosine, including repackagers and relabelers. The FDA regulates 3,5-Dibromo-L-Tyrosine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3,5-Dibromo-L-Tyrosine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 3,5-Dibromo-L-Tyrosine supplier is an individual or a company that provides 3,5-Dibromo-L-Tyrosine active pharmaceutical ingredient (API) or 3,5-Dibromo-L-Tyrosine finished formulations upon request. The 3,5-Dibromo-L-Tyrosine suppliers may include 3,5-Dibromo-L-Tyrosine API manufacturers, exporters, distributors and traders.
3,5-Dibromo-L-Tyrosine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 3,5-Dibromo-L-Tyrosine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 3,5-Dibromo-L-Tyrosine GMP manufacturer or 3,5-Dibromo-L-Tyrosine GMP API supplier for your needs.
A 3,5-Dibromo-L-Tyrosine CoA (Certificate of Analysis) is a formal document that attests to 3,5-Dibromo-L-Tyrosine's compliance with 3,5-Dibromo-L-Tyrosine specifications and serves as a tool for batch-level quality control.
3,5-Dibromo-L-Tyrosine CoA mostly includes findings from lab analyses of a specific batch. For each 3,5-Dibromo-L-Tyrosine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
3,5-Dibromo-L-Tyrosine may be tested according to a variety of international standards, such as European Pharmacopoeia (3,5-Dibromo-L-Tyrosine EP), 3,5-Dibromo-L-Tyrosine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (3,5-Dibromo-L-Tyrosine USP).
LOOKING FOR A SUPPLIER?
